Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
1,536
Showing 50 of 1,536
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 51 | NNBR | Nn Inc | 186 | 16 | 77% | +31.6% | +22.6% | +106.1% | -10.8% |
| 52 | GCO | Genesco Inc | 24 | 7 | 88% | +31.4% | +38.0% | +40.1% | -13.0% |
| 53 | OPTT | Ocean Power Technologies, Inc. | 11 | 4 | 55% | +31.4% | +2.0% | +150.0% | -20.5% |
| 54 | HBIO | Harvard Bioscience Inc | 15 | 6 | 80% | +31.3% | +14.6% | +88.8% | -6.4% |
| 55 | RPAY | Repay Holdings Corp | 41 | 9 | 93% | +30.0% | +30.1% | +55.0% | -0.4% |
| 56 | ECOR | Electrocore, Inc. | 27/28 | 6 | 78% | +29.9% | +17.4% | +110.0% | -27.6% |
| 57 | CBRL | Cracker Barrel Old Country Store, Inc | 50 | 5 | 100% | +29.6% | +32.8% | +40.0% | +14.9% |
| 58 | EOSE | Eos Energy Enterprises, Inc. | 26 | 12 | 77% | +29.6% | +37.8% | +56.6% | -28.6% |
| 59 | FOA | Finance of America Companies Inc. | 136 | 35 | 93% | +29.6% | +35.5% | +63.4% | -14.9% |
| 60 | FULC | Fulcrum Therapeutics, Inc. | 13 | 5 | 62% | +29.5% | +52.5% | +52.5% | -19.4% |
| 61 | AIM | Aim Immunotech Inc. | 33 | 6 | 42% | +29.4% | 0.0% | +233.3% | -30.8% |
| 62 | KROS | Keros Therapeutics, Inc. | 22/23 | 5 | 95% | +29.2% | +32.1% | +32.1% | -10.3% |
| 63 | CNSP | Cns Pharmaceuticals, Inc. | 10/11 | 5 | 60% | +28.9% | +46.2% | +112.3% | -53.5% |
| 64 | SEZL | Sezzle Inc. | 21/40 | 3 | 67% | +28.5% | +22.8% | +129.0% | -87.2% |
| 65 | PLSE | Pulse Biosciences, Inc. | 37/41 | 5 | 76% | +28.4% | +32.5% | +59.3% | -14.8% |
| 66 | AMST | Amesite Inc. | 10 | 3 | 80% | +28.3% | +19.1% | +75.5% | -8.1% |
| 67 | PRAX | Praxis Precision Medicines, Inc. | 41 | 9 | 95% | +27.0% | +21.4% | +95.1% | -40.2% |
| 68 | SCLX | Scilex Holding Co | 15 | 7 | 33% | +27.0% | -29.9% | +147.1% | -35.3% |
| 69 | OCUL | Ocular Therapeutix, Inc | 21 | 8 | 62% | +26.8% | +4.3% | +118.8% | -18.4% |
| 70 | UAMY | United States Antimony Corp | 15 | 5 | 53% | +26.8% | +1.5% | +215.8% | -11.1% |
| 71 | AIRJ | Airjoule Technologies Corp. | 14 | 6 | 79% | +25.8% | +42.9% | +45.6% | -6.8% |
| 72 | RDZN | Roadzen Inc. | 34 | 3 | 53% | +25.6% | +6.7% | +215.4% | -55.3% |
| 73 | JSPR | Jasper Therapeutics, Inc. | 41 | 27 | 80% | +25.3% | +9.8% | +52.8% | -26.9% |
| 74 | PRM | Perimeter Solutions, SA | 14 | 7 | 100% | +25.3% | +18.2% | +45.1% | +9.9% |
| 75 | DASH | Doordash, Inc. | 197 | 29 | 100% | +25.3% | +30.5% | +30.5% | +15.9% |
| 76 | UA | Under Armour, Inc. | 52/58 | 7 | 88% | +25.2% | +25.3% | +41.7% | -21.9% |
| 77 | UHG | United Homes Group, Inc. | 30/34 | 10 | 70% | +25.0% | +5.5% | +91.5% | -6.9% |
| 78 | ZNTL | Zentalis Pharmaceuticals, Inc. | 12 | 12 | 67% | +24.7% | +10.3% | +80.0% | -17.1% |
| 79 | MDRX | Veradigm Inc. | 102 | 10 | 100% | +24.0% | +27.2% | +30.2% | +14.5% |
| 80 | ABEO | Abeona Therapeutics Inc. | 10 | 5 | 80% | +23.9% | +21.7% | +91.9% | -6.3% |
| 81 | ADV | Advantage Solutions Inc. | 76/78 | 5 | 89% | +23.7% | +19.6% | +75.6% | -30.0% |
| 82 | INMB | Inmune Bio, Inc. | 13 | 4 | 85% | +23.2% | +34.2% | +49.7% | -20.5% |
| 83 | ROLR | High Roller Technologies, Inc. | 30 | 9 | 50% | +23.0% | -7.8% | +787.0% | -44.1% |
| 84 | DOUG | Douglas Elliman Inc. | 37 | 7 | 78% | +22.9% | +14.3% | +92.4% | -32.5% |
| 85 | RZLT | Rezolute, Inc. | 60 | 9 | 80% | +22.9% | +26.7% | +73.0% | -75.9% |
| 86 | AIMD | Ainos, Inc. | 10/14 | 4 | 90% | +22.5% | +20.3% | +55.8% | -9.6% |
| 87 | LEU | Centrus Energy Corp | 33 | 3 | 79% | +22.5% | +34.9% | +34.9% | -7.9% |
| 88 | REZI | Resideo Technologies, Inc. | 74 | 5 | 97% | +21.9% | +22.7% | +40.9% | -6.8% |
| 89 | LIFW | Msp Recovery, Inc. | 16/18 | 6 | 56% | +21.8% | +49.1% | +92.2% | -36.1% |
| 90 | LXEO | Lexeo Therapeutics, Inc. | 12 | 12 | 92% | +21.7% | +24.3% | +24.3% | -6.2% |
| 91 | AP | Ampco Pittsburgh Corp | 25/26 | 9 | 72% | +21.7% | +19.9% | +114.9% | -14.8% |
| 92 | SG | Sweetgreen, Inc. | 66/68 | 8 | 98% | +21.6% | +20.7% | +79.2% | -0.3% |
| 93 | LUMN | Lumen Technologies, Inc. | 18 | 5 | 78% | +21.5% | +32.1% | +47.2% | -9.9% |
| 94 | ENGN | Engene Holdings Inc. | 29 | 3 | 72% | +21.3% | +31.1% | +46.1% | -12.5% |
| 95 | APCX | Apptech Payments Corp. | 19/22 | 4 | 68% | +21.2% | +20.5% | +184.8% | -33.3% |
| 96 | CMPX | Compass Therapeutics, Inc. | 43 | 7 | 65% | +21.1% | +12.1% | +68.9% | -20.9% |
| 97 | PAYS | Paysign, Inc. | 66 | 5 | 80% | +21.1% | +15.7% | +58.4% | -16.0% |
| 98 | BCAB | Bioatla, Inc. | 13 | 4 | 77% | +21.0% | +29.3% | +57.5% | -28.0% |
| 99 | ANNX | Annexon, Inc. | 30/32 | 8 | 80% | +21.0% | +21.5% | +62.3% | -33.4% |
| 100 | ELUT | Elutia Inc. | 64/96 | 22 | 91% | +21.0% | +19.7% | +62.0% | -30.8% |